Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S, Pilishvili T, Derado G, Soe MM, Dollard P, Wu H, Li Q, Bagchi S, Dubendris H, Link-Gelles R, Jernigan JA, Budnitz D, Bell J, Benin A, Shang N, Edwards JR, Verani JR, Schrag SJ. Nanduri S, et al. Among authors: pilishvili t. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437519 Free PMC article.
Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.
De Serres G, Pilishvili T, Link-Gelles R, Reingold A, Gershman K, Petit S, Farley MM, Harrison LH, Lynfield R, Bennett NM, Baumbach J, Thomas A, Schaffner W, Beall B, Whitney C, Moore M. De Serres G, et al. Among authors: pilishvili t. Vaccine. 2012 Jun 8;30(27):4067-72. doi: 10.1016/j.vaccine.2012.04.017. Epub 2012 Apr 21. Vaccine. 2012. PMID: 22525797
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
Pilishvili T, Fleming-Dutra KE, Farrar JL, Gierke R, Mohr NM, Talan DA, Krishnadasan A, Harland KK, Smithline HA, Hou PC, Lee LC, Lim SC, Moran GJ, Krebs E, Steele M, Beiser DG, Faine B, Haran JP, Nandi U, Schrading WA, Chinnock B, Henning DJ, LoVecchio F, Nadle J, Barter D, Brackney M, Britton A, Marceaux-Galli K, Lim S, Phipps EC, Dumyati G, Pierce R, Markus TM, Anderson DJ, Debes AK, Lin M, Mayer J, Babcock HM, Safdar N, Fischer M, Singleton R, Chea N, Magill SS, Verani J, Schrag S; Vaccine Effectiveness Among Healthcare Personnel Study Team. Pilishvili T, et al. MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):753-758. doi: 10.15585/mmwr.mm7020e2. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34014909 Free PMC article.
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
Pilishvili T, Gierke R, Fleming-Dutra KE, Farrar JL, Mohr NM, Talan DA, Krishnadasan A, Harland KK, Smithline HA, Hou PC, Lee LC, Lim SC, Moran GJ, Krebs E, Steele MT, Beiser DG, Faine B, Haran JP, Nandi U, Schrading WA, Chinnock B, Henning DJ, Lovecchio F, Lee J, Barter D, Brackney M, Fridkin SK, Marceaux-Galli K, Lim S, Phipps EC, Dumyati G, Pierce R, Markus TM, Anderson DJ, Debes AK, Lin MY, Mayer J, Kwon JH, Safdar N, Fischer M, Singleton R, Chea N, Magill SS, Verani JR, Schrag SJ; Vaccine Effectiveness among Healthcare Personnel Study Team. Pilishvili T, et al. N Engl J Med. 2021 Dec 16;385(25):e90. doi: 10.1056/NEJMoa2106599. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551224 Free PMC article.
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
Prasad N, Derado G, Nanduri SA, Reses HE, Dubendris H, Wong E, Soe MM, Li Q, Dollard P, Bagchi S, Edwards J, Shang N, Budnitz D, Bell J, Verani JR, Benin A, Link-Gelles R, Jernigan J, Pilishvili T. Prasad N, et al. Among authors: pilishvili t. MMWR Morb Mortal Wkly Rep. 2022 May 6;71(18):633-637. doi: 10.15585/mmwr.mm7118a4. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35511708 Free PMC article.
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
Hatfield KM, Baggs J, Wolford H, Fang M, Sattar AA, Montgomery KS, Jin S, Jernigan J, Pilishvili T. Hatfield KM, et al. Among authors: pilishvili t. Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S147-S154. doi: 10.1093/cid/ciac562. Clin Infect Dis. 2022. PMID: 35856635 Free PMC article.
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
McConeghy KW, White EM, Blackman C, Santostefano CM, Lee Y, Rudolph JL, Canaday D, Zullo AR, Jernigan JA, Pilishvili T, Mor V, Gravenstein S. McConeghy KW, et al. Among authors: pilishvili t. MMWR Morb Mortal Wkly Rep. 2022 Sep 30;71(39):1235-1238. doi: 10.15585/mmwr.mm7139a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36173757 Free PMC article.
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.
Prasad N, Rhodes J, Deng L, McCarthy NL, Moline HL, Baggs J, Reddy SC, Jernigan JA, Havers FP, Sosin DM, Thomas A, Lynfield R, Schaffner W, Reingold A, Burzlaff K, Harrison LH, Petit S, Farley MM, Herlihy R, Nanduri S, Pilishvili T, McNamara LA, Schrag SJ, Fleming-Dutra KE, Kobayashi M, Arvay M. Prasad N, et al. Among authors: pilishvili t. J Infect Dis. 2023 Apr 12;227(7):907-916. doi: 10.1093/infdis/jiad028. J Infect Dis. 2023. PMID: 36723871 Free PMC article.
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods.
Ciesla AA, Wiegand RE, Smith ZR, Britton A, Fleming-Dutra KE, Miller J, Accorsi EK, Verani JR, Shang N, Derado G, Pilishvili T, Link-Gelles R. Ciesla AA, et al. Among authors: pilishvili t. Open Forum Infect Dis. 2023 Apr 13;10(5):ofad187. doi: 10.1093/ofid/ofad187. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37213428 Free PMC article.
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T; Centers for Disease Control and Prevention (CDC). Tomczyk S, et al. Among authors: pilishvili t. MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5. MMWR Morb Mortal Wkly Rep. 2014. PMID: 25233284 Free PMC article.
101 results